– Interview with Joshua Boger, Ph.D., Founder and CEO, Vertex Pharmaceuticals, and Chairman, Board of Directors, Biotechnology Industry Organization (BIO), and James Greenwood, President and CEO, BIO

Previous articleGene Expression Ratio Test Predicts Post-Surgery Outcome in Mesothelioma
Next articleUMass Boston Opens Venture Development Center to Augment Collaborations